Uncategorized

Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches

Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches

Published

4 hours ago

on

After receiving the FDA’s greenlight for Hunter syndrome drug Avlayah, Denali Therapeutics CEO Ryan Watts saw the culmination of 20 years of hard work unraveling the mysteries of the blood-brain barrier.​ ​Read More

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version